Dermapharm Holding SE
Research Dermapharm Holding SE (DMP) on Bullrun: market cap EUR 1.99B, P/E 15.0, dividend yield 2.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerDMP
- ExchangeXETRA
- CountryGermany
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Market capEUR 1.99B
- P/E15.0
- Dividend yield2.2%
- Financial periodQ1 2026
- RevenueEUR 305.80M
- Net incomeEUR 45.20M
- Free cash flowEUR 47.97M
- Gross margin67.9%
Valuation Snapshot
latest market cap is EUR 1.99B; P/E is 15.0; dividend yield is 2.2%.
Peer valuation comparison
Latest P/E is 14.99x versus a Healthcare sector median of 24.46x (38.7% below).
Latest dividend yield is 2.23% versus a Healthcare sector median of 2.11% (5.7% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 1.16B | EUR 132.41M | EUR 187.03M | 67.2% | n/a | EUR 203.41M | EUR 1.05B | EUR 694.38M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | EUR 1.99B | 15.0 | 2.2% | 0.88 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.88 EUR, yield 2.2%.
About Dermapharm Holding SE
Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China. The company operates through three segments: Branded Pharmaceuticals; Other Healthcare Products; and Parallel Import Business.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Dermapharm Holding SE's market cap?
Dermapharm Holding SE's market capitalization is EUR 1.99B.
What is Dermapharm Holding SE's P/E ratio?
Dermapharm Holding SE's price-to-earnings (P/E) ratio is 15.0.
Does Dermapharm Holding SE pay a dividend?
Dermapharm Holding SE has a dividend yield of 2.2%.
What does Dermapharm Holding SE do?
Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China. The company operates through three segments: Branded Pharmaceuticals; Other Healthcare Products; and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals.